Correlation Between Te Chang and GeneFerm Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Te Chang and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Te Chang and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Te Chang Construction and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on Te Chang and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Te Chang with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Te Chang and GeneFerm Biotechnology.

Diversification Opportunities for Te Chang and GeneFerm Biotechnology

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between 5511 and GeneFerm is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Te Chang Construction and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and Te Chang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Te Chang Construction are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of Te Chang i.e., Te Chang and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between Te Chang and GeneFerm Biotechnology

Assuming the 90 days trading horizon Te Chang is expected to generate 6.52 times less return on investment than GeneFerm Biotechnology. But when comparing it to its historical volatility, Te Chang Construction is 1.29 times less risky than GeneFerm Biotechnology. It trades about 0.02 of its potential returns per unit of risk. GeneFerm Biotechnology Co is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  4,760  in GeneFerm Biotechnology Co on September 13, 2024 and sell it today you would earn a total of  115.00  from holding GeneFerm Biotechnology Co or generate 2.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Te Chang Construction  vs.  GeneFerm Biotechnology Co

 Performance 
       Timeline  
Te Chang Construction 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Te Chang Construction are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Te Chang may actually be approaching a critical reversion point that can send shares even higher in January 2025.
GeneFerm Biotechnology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, GeneFerm Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Te Chang and GeneFerm Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Te Chang and GeneFerm Biotechnology

The main advantage of trading using opposite Te Chang and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Te Chang position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.
The idea behind Te Chang Construction and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm